Cargando…
Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer
INTRODUCTION: Despite the benefits of endocrine therapies such as tamoxifen and aromatase inhibitors in treating estrogen receptor (ER) alpha-positive breast cancer, many tumors eventually become resistant. The molecular mechanisms governing resistance remain largely unknown. Pigment epithelium-deri...
Autores principales: | Jan, Rifat, Huang, Min, Lewis-Wambi, Joan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906603/ https://www.ncbi.nlm.nih.gov/pubmed/23151593 http://dx.doi.org/10.1186/bcr3356 |
Ejemplares similares
-
Retraction Note: Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer
por: Jan, Rifat, et al.
Publicado: (2023) -
Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA
por: Hayes, Erin L, et al.
Publicado: (2015) -
Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death
por: Choi, Hye Joung, et al.
Publicado: (2015) -
The effects of pigment epithelium-derived factor on atherosclerosis: putative mechanisms of the process
por: Ma, Shouyuan, et al.
Publicado: (2018) -
Cancer-associated Nummular Loss of the Retinal Pigment Epithelium
por: Lee, Jun Mok, et al.
Publicado: (2007)